Dose-finding trial paves way for new rotavirus vaccine to prevent a deadly diarrheal disease from…
A phase 2 clinical trial has found that the Australian-developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies. The immune response generated was similar in the group given a reduced dose…